Animal reuse in safety assessment studies: a review of current practices, challenges and 3Rs opportunities
John S. Kendrick, David A. Shaw, Marie Jourdain, Claudia Senn, Helen Beyer, Fiona R. Sewell · 2026
Read Animal reuse in safety assessment studies: a review of current practices, challenges and 3Rs opportunities by John S. Kendrick, David A. Shaw, Marie Jourdain, Claudia Senn, Helen Beyer, Fiona R. Sewell (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616529.txt.
Description
John Kendrick, David Shaw, Marie Jourdain and colleagues review the reuse of animals in drug safety studies in 2026. Most safety work uses fresh animals to avoid carry-over effects, yet reuse is already normal in pharmacokinetic and safety pharmacology studies.
Reusing animals can cut total numbers and spare them transport, quarantine and settling into new surroundings. The risks are real too: lifetime burden builds up, washout periods must be long enough, and prior treatments can trigger immune reactions. The authors propose a three-tier framework that sorts studies by how feasible reuse is, and they call for shared decision tools and early talks with regulators and contract labs.
Catalog record
| CREATOR | John S. Kendrick, David A. Shaw, Marie Jourdain, Claudia Senn, Helen Beyer, Fiona R. Sewell |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |